Cradle
Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
About
Cradle Bio B.V. is a Dutch-Swiss biotechnology company that develops software using machine learning for protein engineering. Their platform accelerates the discovery and development of proteins by enabling faster engineering processes, reducing experimental rounds, and optimizing multiple objectives simultaneously.
Key facts
At-a-glance profile data
- Website
- cradle.bio
- Headquarters
- Amsterdam, Netherlands
- Founded
- 2021
- Employees
- 112
- Total funding
- $102M (Series B)
- Business model
- B2B
- Tags
- BiotechHealthTechAI-Driven Protein DesignDrug DiscoveryGenerative AI
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 26 Nov 2024 | Series B | $73M | IVP |
| 28 Nov 2023 | Series A | $24M | Index Ventures |
| 17 Nov 2022 | Seed | $5M | Index Ventures |
Tech stack
Detected on cradle.bio, last scanned 27 Sept 2026. Run your own scan
- CMS / Builders
- Framer, Squarespace
- Email provider
- Google Workspace
- Status page
- BetterStack
Frequently asked
What does Cradle do?
They serve industries such as pharmaceuticals, chemicals, food, and agriculture.
How much funding has Cradle raised?
Cradle has raised a total of $102M in funding. The most recent round on record is Series B.
How many employees does Cradle have?
Cradle has approximately 112 people on record.
Recursion OS
Cradle and Recursion both leverage AI and machine learning for drug discovery and protein engineering, aiming to accelerate the development of new therapeutics.
Twist Bioscience platform
While Twist Bioscience focuses on synthetic DNA, Cradle's protein engineering platform could be seen as a complementary or alternative approach for companies seeking to design and optimize biological molecules for various applications.
Biopharma
Johnson & Johnson, a global healthcare giant, is already a customer, utilizing Cradle's platform to accelerate research and development of protein-based products.
Industrial Biotechnology
Novonesis, a biosolutions company, is a customer that partners with Cradle to embed advanced AI into their innovation process, aiming to shorten development time for biosolutions.
Pharmaceuticals
Lundbeck, a pharmaceutical company specializing in brain diseases, is a customer that partners with Cradle for AI-driven brain disorder treatment discovery and optimization.
Confirmed customer relationships for Cradle. Speculative buyer-fit guesses are not shown.